Symbolic illustration of joint replacement infection prevention.

Joint Replacement Infections: What You Need to Know

"A closer look at prosthetic joint infections, their causes, and preventative measures."


Joint replacement surgery has become a common and effective procedure for improving the quality of life for individuals suffering from chronic joint pain and mobility issues. While these surgeries generally have high success rates, prosthetic joint infections (PJIs) remain a serious complication that can lead to significant morbidity, prolonged hospital stays, and additional surgical interventions.

A recent study by Erik Lenguerrand and colleagues, published in The Lancet Infectious Diseases, highlighted important modifiable risk factors associated with PJIs following hip arthroplasty. Their work underscores the need for a comprehensive understanding of the factors contributing to these infections and the implementation of strategies to minimize their occurrence.

This article delves into the complexities surrounding prosthetic joint infections, drawing insights from the latest research and expert opinions to provide a clear and accessible overview of this critical issue. We will explore the incidence, risk factors, diagnosis, prevention, and management of PJIs, with the aim of empowering patients and healthcare professionals to make informed decisions and improve outcomes.

AI Search Multiple angles on this topic

Incidence and Clinical Impact

A 2023 cohort study examined prosthetic joint infection (PJI) incidence, microbiology, and associated patient and surgical factors at three time points after total knee arthroplasty among US veterans. The supplied source information does not report the study’s incidence figures, so no rate can be stated here. A clinical review describes PJI as a serious complication of prosthetic joint implantation, including total hip and total knee arthroplasty.

A Long History of Joint Surgery

A historical overview notes that joint diseases have troubled people since ancient times. It credits generations of surgeons with introducing surgical techniques and advancing implant materials and designs. The overview also reports that prosthetic joint infections were a major reason for development in this field, though the provided snippet does not specify particular milestones or dates.

Understanding the Scope of Prosthetic Joint Infections

Symbolic illustration of joint replacement infection prevention.

Prosthetic joint infections can occur at any time after joint replacement surgery, but they are broadly classified into early-onset and late-onset infections. Early-onset infections typically manifest within the first few months after surgery, while late-onset infections occur more than 24 months post-implantation. A study found that 42% of prosthetic joint infections were diagnosed as late-onset infections, highlighting the importance of long-term monitoring and vigilance.

Distinguishing between early- and late-onset infections is crucial for determining the appropriate diagnostic and treatment strategies. Early-onset infections are often caused by virulent bacteria introduced during surgery, whereas late-onset infections may result from hematogenous spread from distant sites or from the reactivation of dormant bacteria within the implant.

  • Early-Onset Infections: Typically occur within the first few months after surgery and are often caused by bacteria introduced during the surgical procedure.
  • Late-Onset Infections: Occur more than 24 months post-implantation and may result from the spread of bacteria from other parts of the body or reactivation of dormant bacteria.
  • Risk Factors: Factors that increase the risk of developing a prosthetic joint infection include obesity, diabetes, compromised immune system, and previous joint surgery.
AI Search Multiple angles on this topic

Recent Reviews and Treatment Research

A review published August 14, 2025, describes PJI as a challenging complication in orthopedic surgery and reports incidence of 1%–2% for primary arthroplasties, with significantly higher rates for revision procedures. It also reports mortality rates of 8%–25% within five years. A separate source lists a June 2026 multicenter retrospective cohort examining predictors of treatment failure for hip and knee PJI treated with one- or two-stage exchange arthroplasty; the supplied material does not give its findings.

Limits in Prevention Evidence

A systematic review and meta-analysis of randomized controlled trials on antibiotics and antiseptics for preventing infection in people receiving primary total hip and knee prostheses identified limits in the evidence. It could not meta-analyze several endpoints because too few randomized trials examined them. The authors also said that, despite a comprehensive search, they could not be fully confident that all trials had been identified. Separately, research on implant surface technology and bacterial adhesion awaits validation in clinical studies.

Comparing Risk and Revision Approaches

In a study of 255,568 patients, Kao et al. reported no difference in PJI risk between total knee arthroplasty (TKA) and total hip arthroplasty (THA) patients who had a dental procedure within two years after arthroplasty and those who did not. For chronic knee PJI, one- and two-stage revision are both described as main treatment options, but the best choice remains debated. A 2023 study concluded that 1.5-stage exchange appeared to be an acceptable alternative to two-stage exchange for hip PJI, with noninferior infection eradication.

The accurate identification and classification of PJIs can be challenging, as the symptoms may be subtle or nonspecific. Furthermore, the diagnosis often relies on the surgeon's clinical judgment, which can be subjective and prone to bias. Standardized, evidence-based algorithms are needed to improve the accuracy and reliability of PJI diagnosis.

Prevention is Key: Reducing Your Risk of Joint Infection

Preventing prosthetic joint infections requires a multifaceted approach involving meticulous surgical technique, appropriate antibiotic prophylaxis, and patient education. By understanding the risk factors and implementing evidence-based strategies, healthcare professionals and patients can work together to minimize the occurrence of these debilitating infections and ensure the long-term success of joint replacement surgery.

AI Search Multiple angles on this topic

Care Requires Coordination

A 2023 review of current clinical challenges in PJI focuses on multidisciplinary collaboration alongside diagnosis and management. A separate narrative review, published December 2, 2025, synthesizes peer-reviewed clinical studies, consensus statements, and major international guidelines addressing PJI in hip, knee, and shoulder arthroplasty. Together, these sources frame PJI care as an area informed by both collaborative practice and a broad evidence base.

Research Trends and Projected Market Growth

A December 2024 bibliometric analysis investigates worldwide research trends, developing patterns, and main areas of focus in artificial joint infection research, with the stated aim of informing clinical practice and therapeutic techniques. Separately, a market analysis published July 15, 2026, projects steady growth in the prosthetic joint infections treatment market through 2034. It attributes that projection to expanding arthroplasty procedure volumes, new reimbursement pathways, and continued innovation in antibiotic delivery and implant surface technology; this is a market projection, not a clinical outcome.

The Burden of PJI

A review describes PJI as a major clinical challenge after total joint arthroplasty. It associates the infection with prolonged antimicrobial therapy, repeated surgery, implant failure, functional disability, and substantial socioeconomic burden. The same source lists systemic antibiotics, debridement with implant retention, staged revision, and antibiotic-loaded approaches among current strategies.

What the prevention figures do and do not show

The comparison reports a lower infection rate with chlorhexidine cloths than with povidone-iodine wash, but it does not by itself establish that the difference was caused by the bathing method.[1]

The evidence base for the meta-analysis was small, follow-up was relatively short, and publication bias was possible. These features make the pooled estimate less secure; the source specifically notes that short follow-up could lead to underestimation of infection rates.[1]

How prevention and incidence estimates depend on the evidence

A separate analysis of prevention strategies relied on indirect comparisons among antibiotic-loaded bone cement, chlorhexidine, and vancomycin. Its direct comparisons between chlorhexidine and povidone-iodine, and between povidone-iodine and vancomycin, each involved only a small set of studies, so the relative effects are not firmly settled.[2]

Registry counts based on revision for infection can miss cases: some infections are treated with antibiotics or debridement and irrigation without revision. Administrative diagnosis and procedure records offer another possible way to identify cases that did not undergo revision.[3]

Late infections may reflect bacteria reaching the implant through the bloodstream or an infection acquired during insertion that manifests later. In another analysis, conclusions about very late infection trends depended on whether cases with uncertain links to the original operation were included.[4] [5]

What remains unresolved in prevention and measurement

  • Would larger randomized comparisons confirm the relative effectiveness of the preventive strategies when the indirect comparisons are replaced with direct evidence?[2]
  • How much do estimates change when infection cases that cannot be linked reliably to an original operation are handled differently?[5]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What are prosthetic joint infections and why are they a concern after joint replacement surgery?

Prosthetic joint infections, or PJIs, are infections that can occur after a joint replacement surgery. They can significantly impact recovery and the long-term success of the implant. Understanding the different types of PJIs, risk factors, and preventative measures are important for both patients and healthcare providers. Early-onset infections typically occur within the first few months post-surgery often due to bacteria introduced during the procedure. Late-onset infections occur later, usually more than two years after the implant, and can result from bacteria spreading from other areas in the body or the reactivation of dormant bacteria. Factors such as obesity, diabetes, or a compromised immune system can increase the risk of developing a PJI.

2

Why is it important to know if an infection is early-onset versus late-onset?

Distinguishing between early-onset and late-onset prosthetic joint infections is important because it affects the diagnostic and treatment approaches. Early-onset infections, appearing within a few months after surgery, are often caused by bacteria introduced during the surgical procedure itself. This might require a different antibiotic strategy or surgical intervention to address the more immediate contamination. Late-onset infections, occurring more than 24 months after surgery, are frequently the result of bacteria spreading from distant sites in the body or the reactivation of bacteria that may have been dormant within the implant. This distinction guides the medical team in determining the source of the infection and tailoring the treatment accordingly.

3

What are some of the risk factors that make someone more likely to get a prosthetic joint infection?

Several factors can increase the likelihood of developing a prosthetic joint infection. These include obesity, diabetes, a compromised immune system, and a history of previous joint surgeries. Obesity and diabetes can impair the body's ability to heal and fight off infections. A compromised immune system, whether due to illness or medication, reduces the body's natural defenses against bacteria. Previous joint surgeries may also increase the risk due to scar tissue and altered blood flow. Understanding these risk factors helps healthcare providers and patients take proactive steps to minimize the chances of infection.

4

How can prosthetic joint infections be prevented?

Preventing prosthetic joint infections involves a comprehensive strategy that includes meticulous surgical techniques, appropriate antibiotic prophylaxis, and thorough patient education. During surgery, strict adherence to sterile procedures minimizes the risk of introducing bacteria into the joint. Antibiotic prophylaxis involves administering antibiotics before, during, and after surgery to prevent bacterial colonization. Patient education ensures that individuals understand the importance of wound care, recognizing early signs of infection, and adhering to post-operative instructions. By implementing these measures, the risk of developing a PJI can be significantly reduced.

5

How are prosthetic joint infections diagnosed?

Diagnosing a prosthetic joint infection can be challenging because the symptoms can be subtle and nonspecific. Doctors often rely on clinical judgment, which can be subjective. Standardized, evidence-based diagnostic algorithms are needed to improve the accuracy and reliability of PJI diagnosis. The symptoms may include persistent pain, swelling, redness, warmth around the joint, fever, or drainage from the surgical site. Because these symptoms can also be present in other post-operative conditions, a thorough evaluation, including blood tests, imaging studies, and joint fluid analysis, is crucial for accurate diagnosis.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.